The Cardiac Amyloidosis and Cardiomyopathy Center, located at the hospital, will focus on diagnosing patients with rare amyloid conditions earlier and providing personalized treatment, a Nov. 17 news release from the health system said.
Amyloidosis is a rare condition caused by an abnormal protein that accumulates in organs which is often misdiagnosed due to its subtle symptoms. At least one type of the amyloidosis can be fatal in six months, according to the release.
The center will include a range of disciplines, such as cardiology, neurology, hematology, nephrology, pathology and bone marrow transplantation.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
